Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| CELG | Celgene Corporation | 0.58% | 86.50 | 1.3% | $1352.34m | |
| AMGN | Amgen Inc. | -0.21% | 201.56 | 1.2% | $603.80m | |
| GILD | Gilead Sciences, Inc. | 0.41% | 68.53 | 0.9% | $537.30m | |
| LOXO | Loxo Oncology Inc | -0.03% | 233.70 | 12.7% | $517.58m | |
| BIIB | Biogen Inc. | -0.51% | 337.22 | 1.3% | $412.55m | |
| VRTX | Vertex Pharmaceuticals Incorporated | -2.06% | 189.89 | 1.9% | $326.56m | |
| ILMN | Illumina, Inc. | -0.44% | 302.29 | 3.5% | $303.21m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -0.88% | 401.21 | 2.6% | $300.94m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 2.37% | 117.00 | 2.0% | $223.30m | |
| EXAS | Exact Sciences Corporation | 4.79% | 79.71 | 25.3% | $149.33m | |
| A | Agilent Technologies, Inc. | 0.45% | 71.64 | 1.5% | $147.28m | |
| INCY | Incyte Corporation | -2.75% | 75.20 | 2.5% | $143.98m | |
| SRPT | Sarepta Therapeutics, Inc. | -1.30% | 118.72 | 15.4% | $129.31m | |
| LGND | Ligand Pharmaceuticals Incorporated | -1.00% | 111.78 | 23.1% | $119.93m | |
| NBIX | Neurocrine Biosciences, Inc. | -2.15% | 89.32 | 5.1% | $95.56m |
Company Profile
XBiotech, Inc. is a biopharmaceutical company, which engages in discovering and developing True Human monoclonal antibodies for treating diseases. It offers MABp1, which targets and neutralizes interleukin-1 alpha, a molecule known to promote angiogenesis, growth and spread of tumors, as well as mediate symptoms such as metabolic dysregulation, fatigue, and anxiety associated with advanced cancer. The company was founded by John Simard on March 22, 2005 and is headquartered in Austin, TX.